About Centre de Santé de Référence Rutshuru
- Top Sponsors
- Top Collaborators
- Trials By Phase
- Recruitment Status
- Top Conditions
- Intervention Types
- Top Intervention Names
- Trials By Gender
Lead Sponsor
# Trials
Clinical Trials at Centre de Santé de Référence Rutshuru
During the past decade, Centre de Santé de Référence Rutshuru conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 0 clinical trials were completed, i.e. on
average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 0 clinical trials were completed. i.e. 0%
of trials that started reached the finish line.
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
LUX-Lung 8: A Phase III Trial of Afatinib (BIBW 2992) Versus Erlotinib for the Treatment of Squamous Cell Lung Cancer After at Least One Prior Platinum Based Chemotherapy
2012-03-05
2017-12-27
Completed
795
Enroll -HD: A Prospective Registry Study in a Global Huntington's Disease Cohort
2012-07-01
2062-01-01
Recruiting
20,000
BI 409306 in Patients With Cognitive Impairment Due to Alzheimer's Disease.
2015-01-21
2017-10-10
Completed
329
Efficacy Study of GS010 for the Treatment of Vision Loss up to 6 Months From Onset in LHON Due to the ND4 Mutation
2016-02-23
2019-07-04
Completed
39
Efficacy Study of GS010 for Treatment of Vision Loss From 7 Months to 1 Year From Onset in LHON Due to the ND4 Mutation (REVERSE)
2016-01-01
2018-12-01
Completed
37
RCT of Non-Invasive Vagus Nerve Stimulation (nVNS) With gammaCore®, for the Acute Treatment of Migraine Attacks
2016-01-01
2017-03-01
Completed
285
Post Authorisation Safety Study With Raxone in LHON Patients
2016-09-01
2021-04-16
Completed
229
Study to Assess the Efficacy and Safety of Raxone in LHON Patients
2016-05-01
2021-03-29
Completed
199
Clinical Trials Sponsors and Collaborators
In terms of collaborators to trials, out of the total clinical trials conducted in "Centre de Santé de Référence Rutshuru"
#1 collaborator was "Institut National de Recherche Biomédicale. Kinshasa, République Démocratique du Congo" with 1 trials as a collaborator, "University of Kinshasa" with 1 trials as a collaborator and "World Health Organization" with 1 trials as a collaborator. Other collaborators include -3 different institutions and companies that were
collaborators in the rest 3 trials.
Clinical Trials Conditions at Centre de Santé de Référence Rutshuru
According to Clinical.Site data, the most researched conditions in "Centre de Santé de Référence Rutshuru" are
"Malaria" (2 trials). Many other conditions were trialed in "Centre de Santé de Référence Rutshuru" in a lesser frequency.
Clinical Trials Intervention Types at Centre de Santé de Référence Rutshuru
Most popular intervention types in "Centre de Santé de Référence Rutshuru" are "Drug" (2 trials). Other intervention types were less common.
The name of intervention was led by "Artemether-lumefantrine" (1 trials), "Artesunate-amodiaquine" (1 trials), "Dihydroartemisinine-piperaquine" (1 trials), "artemether-lumefantrine" (1 trials) and "artesunate-amodiaquine" (1 trials). Other intervention names were less common.
Clinical Trials Genders at Centre de Santé de Référence Rutshuru
The vast majority of trials in "Centre de Santé de Référence Rutshuru" are
2 trials for "All" genders.
Clinical Trials Status at Centre de Santé de Référence Rutshuru
Currently, there are NaN active trials in "Centre de Santé de Référence Rutshuru".
undefined are not yet recruiting,
undefined are recruiting,
undefined are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 2 completed trials in Centre de Santé de Référence Rutshuru,
undefined suspended trials,
and undefined terminated clinical trials to date.
Out of the total trials that were conducted in Centre de Santé de Référence Rutshuru, 0 "Phase 1"
clinical trials were conducted, 0 "Phase 2" clinical
trials and 0 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 2 trials, and there were
also 0 trials that are defined as “Not Applicable".